The protective effect on Cu2+- and AAPH-mediated oxidation of human low-density lipoproteins depends on glycosaminoglycan structure

被引:14
作者
Volpi, N
Tarugi, P
机构
[1] Univ Modena, Dept Anim Biol, Biol Chem Sect, I-41100 Modena, Italy
[2] Univ Modena, Dept Biomed Sci, Gen Pathol Sect, I-41100 Modena, Italy
关键词
low-density lipoprotein; heparin; heparan; dermatan; chondroitin;
D O I
10.1016/S0300-9084(99)00224-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effect of various glycosaminoglycans on Cu2+- and AAPH-induced oxidation of human low-density lipoprotein (LDL) was studied by monitoring conjugated diene formation. Heparin (Hep) increased the lag phase (t(lag)) of LDL oxidation, and fast moving and slow moving Hep species modified the kinetics of LDL oxidation to the same extent. Beef spleen heparan sulfate (HS) sample produced a significant increase of the t(lag) and a decrease of the conjugated diene formation of LDL whilst beef kidney HS species modified LDL oxidation kinetics to a lower extent. Dermatan sulfate (DS) from different sources caused a significant increase of the t(lag) and a decrease of the conjugated diene formation of LDL. Hyaluronic acid had no effect. Chondroitin sulfate (CS) from beef trachea produced a very strong protective antioxidant effect evaluated by increasing of the t(lag) and decreasing of the conjugated diene formation. Hep was completely ineffective in protecting LDL from 2,2'-azobis(2-amidinopropane) hydrochloride (AAPH)-mediated oxidation, whilst DS was moderately effective. Beef trachea CS showed a very strong ability to protect LDL oxidation induced by 1 mM AAPH. The different protective effect on Cu2+- and AAPH-induced LDL oxidation by glycosaminoglycans is discussed considering their various structures and properties, and their capacity to interact to different extents with hydrophobic regions of LDL protein is confirmed by measuring the LDL-tryptophan fluorescence kinetics. (C) 1999 Societe francaise de biochimie et biologie moleculaire / Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:955 / 963
页数:9
相关论文
共 30 条
[11]   OXIDIZED LIPOPROTEINS IN ATHEROSCLEROSIS AND THROMBOSIS [J].
HOLVOET, P ;
COLLEN, D .
FASEB JOURNAL, 1994, 8 (15) :1279-1284
[12]   GLYCOSAMINOGLYCANS - MOLECULAR-PROPERTIES, PROTEIN INTERACTIONS, AND ROLE IN PHYSIOLOGICAL PROCESSES [J].
JACKSON, RL ;
BUSCH, SJ ;
CARDIN, AD .
PHYSIOLOGICAL REVIEWS, 1991, 71 (02) :481-539
[13]   ROLE OF LIPOPROTEIN-COPPER COMPLEX IN COPPER CATALYZED-PEROXIDATION OF LOW-DENSITY-LIPOPROTEIN [J].
KUZUYA, M ;
YAMADA, K ;
HAYASHI, T ;
FUNAKI, C ;
NAITO, M ;
ASAI, K ;
KUZUYA, F .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1123 (03) :334-341
[14]  
Lindahl, 1989, HEPARIN CHEM BIOL PR, P51
[15]   Lipoperoxidative injury to macrophages by oxidatively modified low density lipoprotein may play an important role in foam cell formation [J].
Liu, SX ;
Zhou, M ;
Chen, Y ;
Wen, WY ;
Sun, MJ .
ATHEROSCLEROSIS, 1996, 121 (01) :55-61
[16]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[17]  
NIKI E, 1990, METHOD ENZYMOL, V186, P100
[18]   PROBUCOL INHIBITS OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN [J].
PARTHASARATHY, S ;
YOUNG, SG ;
WITZTUM, JL ;
PITTMAN, RC ;
STEINBERG, D .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (02) :641-644
[19]   STRUCTURAL DIFFERENCES OF DERMATAN SULFATES FROM DIFFERENT ORIGINS [J].
POBLACION, CA ;
MICHELACCI, YM .
CARBOHYDRATE RESEARCH, 1986, 147 (01) :87-100
[20]  
PUHL H, 1994, METHOD ENZYMOL, V233, P425